THE ROLE OF VITAMIN D IN THE PATHOGENESIS OF CHRONIC NON-COMMUNICABLE DISEASES
https://doi.org/10.14341/osteo2014327-30
Abstract
This review shows the role of vitamin D in the regulation of not only the level of calcium, but also in the pathogenesis of chronic systemic inflammation, disruption of insulin sensitivity of tissues. The sufficient levels of vitamin D in the blood can lead to reduced risk of developing type 2 diabetes, obesity, autoimmune destruction of pancreatic β-cells, certain cardiometa-bolic risk factors, and therefore cardiovascular disease. Perhaps preparations of vitamin D in the near future may become additional and necessary nutritional substances for correction of insulin resistance, cardiovascular disease, chronic inflammation and prevention of disorders of glucose metabolism.
References
1. Stojanovic O., Lazovic M., Lazovic M., Vuceljic M. Association between atherosclerosis and osteoporosis, the role of vitamin D. Arch. Med. Sci. 2011. 7, 179-188
2. Summerday N., Brown S., Allington D., Rivey M. Vitamin D and multiple sclerosis: review of a possible association. J. Pharm.Pract. 2012. 25, 75-84
3. Szekely J., Pataki A. Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review. Expert Rev. Respir. Med. 2012. 6, 683-704.
4. Дудинская Е.Н., Ткачева О.Н. Роль витамина D в развитии артериальной гипертензии. кардиоваскулярная терапия и профилактика. 2012. Т. 11. № 4, с. 93-100.
5. Parker J., Hashmi O., Dutton D. et al., «Levels of vitamin D and cardiometabolic disorders: systematic review and metaanalysis,» Maturitas, 2010. 65 (3) 225-236
6. Kai Yin, Devendra K Agrawal. Vitamin D and inflammatory diseases. Journal of Inflammation Research 2014: 7 69-87
7. Querfeld U. Vitamin D and inflammation. Pediatr Nephrol. 2013; 28: 605-610.
8. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80: 1689-1696
9. Holick M.F. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-72
10. Holick M.F. Vitamin D Deficiency. N Engl J Med 2007; 357: 266-281July 19, 2007
11. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am J Physiol Renal Phys 2005; 289: 8-28.
12. Rosen C.J. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011; 364: 248-254
13. Соломатина Л.В. Роль хронического системного воспаления в патогенезе терминальной почечной недостаточности у пациентов, получающих заместительную терапию программным гемодиализом. Автореферат диссертации 2012 г
14. Вельков В.В., С-реактивный белок - в лабораторной диагностике острых воспалений и в оценке рисков сосудистых патологий Клинико-лабораторный консилиум. 2008. 2(21)37-48
15. Liu L.C., Voors A.A., van Veldhuisen D.J., et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2011; 13: 619-625
16. Gao D., Trayhurn P., Bing C. 1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int. J. Obes. Lond. 2013, 37, 357-365
17. Wamberg L., Cullberg K., Rejnmark L., et al. Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial. Horm. Metab. Res. 2013, 45, 456-462
18. Griffin M., Lutz W., Phan V.A., et al. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A. 2001; 98: 6800-6805.
19. Piemonti L., Monti P., Sironi M., et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 2000; 164: 4443-4451
20. Takeda M., Yamashita T., Sasaki N., et al. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol. 2010; 30: 2495-2503
21. Mayne C., Spanier J., Relland L., et al. 1,25Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol. 2011; 41: 822-832.
22. Jeffery L.E., Burke F., Mura M., et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009; 183: 5458-5467
23. Edfeldt K., Liu P.T., Chun R., et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A. 2010; 107: 22593-22598.
24. Timmermans P., Wong P., Chiu A., et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev.1993; 45: 205-251
25. Sowers J.R., Whaley-Connell A., Epstein M. The emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.Ann Intern Med. 2009; 150: 776-783.
26. Bomback A.S., Klemmer P.J. Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease.Am J Nephrol. 2009; 30(2): 140-146.
27. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulaes NADH and NADPH oxidase activity in cultures vascular smooth muscle cells. Circ Res. 1994; 74: 1141-1148
28. Greider C.W., Blackburn E.H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987; 51: 887-898
29. Li C., Qiao G., Uskokovic M., et al. Vitamin D: a negative endocrine regulator of the reninangiotensin system and blood pressure. J of Steroid Bioch and Molec Biol. 2004, 89-90
30. Yasue S., Masuzaki H., Okada S., et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens (2010) 23: 425-3110.1038/ajh.2009.263
31. Vaidya A., Forman J., Underwood P., et al. The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol (2011) 164: 995-100210
32. Yu S., Bruce D., Froicu M., et al. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci U S A. 2008; 105: 20834-20839
33. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311: 1770-1773. 20.
34. Krutzik S.R., Hewison M., Liu P.T., et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol. 2008; 181: 7115-7120.
35. Korf H., Wenes M., Stijlemans B., et al. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology. 2012; 217: 1292-1300.
36. Adorini, L. and Penna, G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol. 2009; 70: 345-352
37. Mai V., McCrary Q., Sinha R., Glei M. Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers. Nutr J. 2009; 8: 49
38. Creely S.; McTernan P.; Kusminski C.; et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endoc. Metab. 2007, 292, 740-747
39. Wu S., Liao A., Xia Y., et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol. 2010; 177: 686-697
40. Konradsen S., Ag H., Lindberg F., et al. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr. 2008. 47: 87-9110
41. Arunabh S., Pollak S., Yeh J. et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003. 88. 157-161
42. Lee P., Greenfield J., Seibel M. et al. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med. 2009. 122(11). 1056-60
43. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation (2000) 102: 1296-30110.1161/01.CIR.102.11.1296
44. Ouchi N., Shibata R., Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med. 2006. 16: 141-610.1016/j.tcm.2006.03.001
45. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med (2008) 168: 1174-8010
46. Wang T., Pencina M., Booth S., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008. 117: 503-1110
47. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J. 2009. 73: 13-810
48. Young K., Engelman C., Langefeld C., et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin End Metab. 2009. 94: 3306-1310.1210/jc.2009-0079
49. Gannage-Yared M., Chedid R., Khalife S., et al. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J End. 2009. 160: 965-7110.1530/ EJE-08-0952
50. Nimitphong H., Chanprasertyothin S., Jongjaroenprasert W., et al. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine. 2009. 36: 205-1010
51. Vaidya A. Vitamin D and cardio-metabolic disease. Metabolism. 2013. 62: 1697
52. Ulutas O., Taskapan H., Taskapan M., et al. Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int Urol Neph. 2013. 45: 879-841
53. de Luis D.A., Soto G.D., Conde R., et al. Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism. J Clin Lab Anal. 2012. 26: 398-40210.1002/jcla.21541
54. Бойцов С.А., Стражеско И.Д., Акашева Д.У., Дудинская Е.Н., Кругликова А.С., Ткачева О.Н. Инсулинорезистентность: благо или зло? механизмы развития и связь с возраст-ассоциированными изменениями сосудов. Кардиоваскулярная терапия и профилактика. 2013. Т. 12. № 4. С. 91-97.
55. Mackawy A., Badawi M. Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients. Meta Gene 2 (2014) 540-556
56. Mathieu C. and Badenhoop K., «Vitamin D and type 1 diabetes mellitus: state of the art,» Trends in Endocrinology and Metabolism, vol. 16, no. 6, pp. 261-266, 2005
57. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004. 27: 2813-810.2337/ diacare.27.12.2813
58. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr (2004) 79: 820-5
59. Takiishi T., Gysemans C., Bouillon R., and Mathieu C., «Vitamin D and diabetes,» Endocrinology and Metabolism Clinics of North America, 2010. 39(2) 419-446
60. Pittas A., Harris S., Stark P., et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diab Care. 2007. 30: 980-610
61. Malecki M., Klupa T., Wolkow P., et al, «Association study of the vitamin D: 1 Alphahydroxylase (CYP1alpha) gene and type 2 diabetes mellitus in a Polish population,» Diabetes and Metabolism, 2003. 29, 2, 19-124
Review
For citations:
Egshatyan L.V., Dudinskaya E.N., Tkacheva O.N., Kashtanova D.A. THE ROLE OF VITAMIN D IN THE PATHOGENESIS OF CHRONIC NON-COMMUNICABLE DISEASES. Osteoporosis and Bone Diseases. 2014;17(3):27-30. (In Russ.) https://doi.org/10.14341/osteo2014327-30
Views:
1808
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
